Invested Today in Africa’s Health Tomorrow

MSD is a global healthcare company with an over 125-year history of working to make a difference. Our commitment to improving the health and wellness of people and animals is exemplified in our long-standing investment in Sub-Saharan Africa. From providing more than 3.4 billion treatments to eliminate river blindness to developing the world’s first globally approved Ebola vaccine to protecting animal health with over 4 billion doses over the past 10 years, MSD has demonstrated this commitment by achieving significant health impact. And while we reflect on our achievements over the past decade, MSD recognizes the need to remain invested to provide leading innovations and solutions for Sub-Saharan Africa’s health today and for the decade to come.

 

Invested Today

in Africa’s Health

Tomorrow

MSD is a global healthcare company with an over 125-year history of working to make a difference. Our commitment to improving the health and wellness of people and animals is exemplified in our long-standing investment in Sub-Saharan Africa. From providing more than 3.4 billion treatments to eliminate river blindness to developing the world’s first globally approved Ebola vaccine to protecting animal health with over 4 billion doses over the past 10 years, MSD has demonstrated this commitment by achieving significant health impact. And while we reflect on our achievements over the past decade, MSD recognizes the need to remain invested to provide leading innovations and solutions for Sub-Saharan Africa’s health today and for the decade to come.

Invent For Life

Invent for Life

Scientific curiosity drives us to invent solutions to some of the world’s most challenging diseases – curiosity that leads, for example, to the first FDA approved preventative HPV Vaccine that is helping to eliminate cervical cancer – one of the leading cancers in Sub-Saharan Africa.

Invest in Resilient Health Systems

The need for investment in resilient health systems has never been more critical than today. COVID-19 has demonstrated the connectedness of our global health system and the need to partner with governments, feet-on-the-ground organizations, health care providers, impact investors, and global institutions to build a stronger and more resilient global health systems that can manage even the most daunting health threats.

Invest in Resilient Health Systems
Innovate for Access

Innovate for Access

MSD is committed to inventing medicines and vaccines that save and improves lives. It’s the most important thing we do. And we know we have to make sure that our inventions get into the hands of people who need them. This requires not only investment in developing our life-saving products, but investing in the broader health ecosystem – training over 30,000 healthcare workers, ensuring over 25 million women can access family planning, and contributing over 60,000 hours of our business and scientific expertise to help solve global health access issues.

Improve our Local Communities

Operating responsibly as a business is at the very heart of MSD’s ability to deliver sustainable impact—driving long-term value for our company and society. We cultivate innovation and excellence by building a diverse and inclusive workforce, who are empowered to succeed, personally and professionally. Our approach to corporate responsibility is about the health, economic, social and environmental impact we have on individuals and communities in Sub-Saharan Africa in which we operate.

Improve our Local Communities